ESC 365 - Chronicity and burden of hyperkalaemia in heart failure: an update.

ESC Premium Access

Chronicity and burden of hyperkalaemia in heart failure: an update.

Session: Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)

Topic: Treatment

Speaker: Professor M. Lainscak (Murska Sobota, SI)

Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Mitja Lainscak

General Hospital Murska Sobota, Murska Sobota (Slovenia)

37 presentations

1 follower

4 more presentations in this session

Introduction

Speaker: Professor S. Anker (Berlin, DE)

Hyperkalaemia: a barrier to guideline-recommended RAASi therapy?

Speaker: Professor S. Anker (Berlin, DE)

The management of hyperkalaemia in heart failure: is there room for improvement?

Speaker: Doctor M. Kosiborod (Kansas City, US)

Towards the state-of-the-art potassium management in heart failure: opportunities and challenges.

Speaker: Professor S. Anker (Berlin, DE) Doctor M. Kosiborod (Kansas City, US) Professor M. Lainscak (Murska Sobota, SI)

Access the full session

Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)

Speakers: Professor M. Lainscak, Professor S. Anker, Professor S. Anker, Doctor M. Kosiborod, Professor S. Anker...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources